UpdatesPress Release
FDC's Q1 FY27 revenue rose 3% to Rs 668 Cr, with PAT up 9.2% to Rs 132 Cr.
FDC LimitedFDC · Filed with the exchange
Strong international formulation sales (+74.2% Y-o-Y), driven by the US business (+118.4%), offset subdued domestic and API segments.
The company secured US FDA approval for Cefixime.
No comments yet. Be the first.